Evidence map›Paper›PMID 36593635›Full record

ArticleBMJ case reports2022

Tuberculous spondylitis following intravesical Bacillus Calmette-Guérin therapy for bladder cancer surgically treated through the anterior approach.

Toshiyuki Shimizu, Yoshiomi Kobayashi, Kanehiro Fujiyoshi, Yoshiyuki Yato

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Toshiyuki ShimizuDepartment of Orthopedic Surgery, Murayama Medical Center, Musashimurayama, Tokyo, Japan.
Yoshiomi KobayashiDepartment of Orthopedic Surgery, Murayama Medical Center, Musashimurayama, Tokyo, Japan ykoba77@me.com.
Kanehiro FujiyoshiDepartment of Orthopedic Surgery, Murayama Medical Center, Musashimurayama, Tokyo, Japan.
Yoshiyuki YatoDepartment of Orthopedic Surgery, Murayama Medical Center, Musashimurayama, Tokyo, Japan.
Murayama Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intravesical BCG therapy is commonly used to treat superficial bladder cancer. Although various complications associated with this therapy have been reported, tuberculous spondylitis is uncommon. Here, we report a rare case of tuberculous spondylitis that occurred after intravesical BCG therapy for bladder cancer. A man in his 80s received BCG immunotherapy for bladder cancer and developed low back pain after treatment. Remarkably, he presented with neurological symptoms. Spondylitis was suspected on imaging. CT-guided biopsy was performed to confirm the diagnosis. Consequently,

Indexed as

BCG VaccineLow Back PainMycobacterium bovisSpondylitisTuberculosis, SpinalUrinary Bladder NeoplasmsAdministration, IntravesicalAged, 80 and overDrug Therapy, CombinationHumansLeprostatic AgentsMaleBCG VaccineLeprostatic AgentsBone and joint infectionsNeurosurgerySpinal cordUrology

Identifiers

PMID36593635
PMCPMC9743316
OpenAlexW4310920214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.